RareBase - Media Partners

12th World Congress on Healthcare and Medical Tourism

12th World Congress on Healthcare and Medical Tourism aims to gather the most elegant societies and industries along with the renowned and honourable persons form top universities across the globe. During this conference series, the international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Healthcare. The conference also welcomes International exhibitions form corporate sectors to showcase the recent advancements in the tools and techniques. In all its ways Health Congress 2017 creates an opportunity to make partnership deals which shall turn into a cent per cent success meet.

The audience of the Health Congress 2017 conference are expected from wide discipline, the conference will be informative and interesting with thought provoking International workshops and International symposiums to the all the participants.

Website

6th annual Orphan Drugs event Berlin

SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019. With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market. Germany is Europe's largest pharma market but is recognised as having one of the toughest pricing policies in Europe. SMi’s 6th annual Orphan Drugs will discuss the controversial German pricing mechanism as well as bring together leading industry professionals to discuss the latest regulatory developments, explore how to reduce costs and learn from the latest innovations in the orphan drug landscape.

Website

Highly Potent Active Pharmaceutical Ingredients

The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions

Website

Drug Discovery 2017

Drug Discovery 2017 aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges. The event will bring together industry leaders who will highlight future opportunities for novel therapeutic discovery. Some of our featured speakers include AstraZeneca, Takeda, Novartis, Johnson & Johnson, Sanofi, GSK, Merck Serono and more.

Website

Orphan Drugs & Rare Diseases Global Congress 2017 Europe

Paradigm Global Events is again proud to present it's bi-annual Orphan Drugs & Rare Diseases Global Congress 2017 Europe. The conference will provide a unique platform for the convergence of stakeholders in the orphan drugs industry to discuss and network with top tier government, hospitals, pharmaceuticals, biopharmaceuticals, non-profit organisations, orphan drugs developers as well as regional and local manufacturers. We are putting together an agenda that address the driving macroeconomic factors, policies and issues that will steer the development of orphan drugs globally including commercialisation, policies, reimbursement, pricing and more.

Website

3rd Biologics & Biosimilars Congress

Following the successful 2016 meeting, Global Engage is pleased to announce the 3rd Biologics & Biosimilars Congress, which will be held on 6-7 March 2017 in Berlin, Germany. The event attracted over 160 attendees last year, and forms part of our successful Drug Discovery series, which includes conferences on synthetic biology, precision medicine, digital pathology and the human microbiome.

Website

Rare Revolution Magazine

Rare Revolution Magazine is dedicated to providing exceptional articles of interest to the rare disease community.
For compelling voices from rare disease advocates, patients and clinical teams and the latest in 'RARE' advancements be part of the #rarerevolution

Website

LegalDNA

Legal-DNA provides advice in matters related to technology transfer arrangments, including research, consortium, sposorship and other funding and collaboraiton agreements and licensing of intellectual property

Website

Pepper Biology

Pepper Biology provides bioinformatics support and consulting for pharmaceutical industry and biomedical research. We work together for efficient and reliable research and better clinical outcomes.

Website

The Ideas Centre Ltd

Seizing control of innovation via breakthough thinking, escaping the limitations of convention and tradition and driving step change (discontinuous improvement).

Website

Personalize My Medicine

Personalize My Medicine places people and patients at center by informing them of the latest advances in medical innovation relevant to their condition and by promoting research and innovation for orphan diseases.

Website

M.Wyborn Consultancy Ltd

Communication requires good understanding but is often the missing piece that should underpin the whole project. We work together with you translating your documents (English/Portuguese) to make sure you receive top quality information.
Email: maria.wyborn@mwyborn.co.uk